ACADSB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.034200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.375800E-01
Normal-vs-Stage2
1.149960E-01
Normal-vs-Stage3
3.766300E-02
Normal-vs-Stage4
4.296800E-01
Stage1-vs-Stage2
8.119600E-02
Stage1-vs-Stage3
6.177500E-02
Stage1-vs-Stage4
5.204400E-01
Stage2-vs-Stage3
1.507620E-01
Stage2-vs-Stage4
6.711200E-01
Stage3-vs-Stage4
1.448180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.947410E-01
Normal-vs-AfricanAmerican
7.273800E-01
Normal-vs-Asian
1.880110E-02
Caucasian-vs-AfricanAmerican
1.276060E-02
Caucasian-vs-Asian
6.811600E-02
AfricanAmerican-vs-Asian
3.606300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.250230E-01
Normal-vs-Female
3.195600E-01
Male-vs-Female
3.746000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.666800E-01
Normal-vs-Age(41-60Yrs)
4.437000E-01
Normal-vs-Age(61-80Yrs)
1.170770E-01
Normal-vs-Age(81-100Yrs)
1.692400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.074300E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.675000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.563400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.671420E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.859200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.926200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.062500E-03
Normal-vs-Daily Drinker
7.364300E-02
Normal-vs-Weekly Drinker
4.646000E-01
Normal-vs-Occasional Drinker
3.602000E-01
Normal-vs-Social Drinker
6.791600E-01
Non Drinker-vs-Daily Drinker
8.070600E-01
Non Drinker-vs-Weekly Drinker
2.938000E-01
Non Drinker-vs-Occasional Drinker
1.799620E-01
Non Drinker-vs-Social Drinker
2.396000E-01
Daily Drinker-vs-Weekly Drinker
3.855600E-01
Daily Drinker-vs-Occasional Drinker
2.781200E-01
Daily Drinker-vs-Social Drinker
2.997400E-01
Weekly Drinker-vs-Occasional Drinker
9.660600E-01
Weekly Drinker-vs-Social Drinker
7.753600E-01
Occasional Drinker-vs-Social Drinker
7.126800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.293500E-02
Normal-vs-Grade 2
3.477800E-02
Normal-vs-Grade 3
3.549900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.554200E-02
Grade 1-vs-Grade 3
6.675800E-02
Grade 1-vs-Grade 4
9.293500E-02
Grade 2-vs-Grade 3
8.109600E-01
Grade 2-vs-Grade 4
3.477800E-02
Grade 3-vs-Grade 4
3.549900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.382620E-01
Normal-vs-NonDiabetic
1.503190E-01
Diabetic-vs-NonDiabetic
9.948400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.687500E-02
Normal-vs-NoPancreatitis
1.778610E-01
Pancreatitis-vs-NoPancreatitis
2.505400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.267200E-01
Normal-vs-N1
1.053830E-01
N0-vs-N1
2.408800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.287190E-01
Normal-vs-TP53-NonMutant
7.796600E-01
TP53-Mutant-vs-TP53-NonMutant
5.560600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
